Swedish euro support remains weak: survey

A survey reveals that Swedish support for the euro remains weak in November, Statistics Sweden announced on Tuesday.

Swedish euro support remains weak: survey

If a referendum on the euro were held in November, about 58 percent would have voted no to joining the currency, while about 29 percent would have voted yes, Statistics Sweden announced in its EU and euro preferences in November 2010 survey on Tuesday.

About 13 percent of respondents said that they did not know how they would vote. The percentage of no votes has decreased compared with May, the agency added.

In May, 60 percent of Swedish respondents indicated that they did not support euro accession, the highest level in the twice-yearly measure since November 1997, compared with 27.8 percent in favour and 12.2 percent who were in unsure.

Support for the euro among Swedish respondents peaked in May 2002, when it was slightly above 45 percent.

In November 2009, 43.8 percent of respondents declared support for the euro, just ahead of 42 percent who were not in favour of the measure, while 14.2 percent did not know how they would vote.

In addition, the proportion of women who would vote yes slightly increased last month, with the proportion who would vote no slightly decreasing. The changes since May were statistically significant.

In November, about 60 percent of female respondents said that they would vote against joining the euro in a referendum, compared with about 62 percent in May. At the same time, the proportion of yes votes among women has increased from about 24 percent in May to about 26 percent in November.

Separately, the proportion who said they mainly support Sweden’s EU membership was about 56 percent, with about 19 percent against and 25 percent stating no opinion.

The number of respondents against Sweden’s EU membership has decreased compared with May. The proportion of those against Sweden’s EU membership has also decreased among women from May. The changes are statistically significant.

The party preference survey comprised telephone interviews of a national random probability sample consisting of 9,054 respondents entitled to vote in the parliamentary election without an upper age limit.

Among the respondents, 13 percent could not be reached (including unlisted telephone numbers and those without telephones), 3.3 percent were too ill to be interviewed and 15.3 percent declined to participate.

The total non-response rate was 31.6 percent. A total of 6,192 interviews were conducted. In addition, certain individuals did not want to answer certain questions.

The interviews were conducted by telephone from October 31st to November 25th. The majority of the interviews were conducted during the first half of the measuring period.

Sixty-nine percent of the interviews had been conducted up to and including November 13th, while 91 percent of the interviews had been conducted up to and including November 21st.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.


Norway to send 200,000 AstraZeneca doses to Sweden and Iceland

Norway, which has suspended the use of AstraZeneca's Covid vaccine until further notice, will send 216,000 doses to Sweden and Iceland at their request, the Norwegian health ministry said Thursday.

Norway to send 200,000 AstraZeneca doses to Sweden and Iceland
Empty vials of the AstraZeneca vaccine. (Photo by GABRIEL BOUYS / AFP)

“I’m happy that the vaccines we have in stock can be put to use even if the AstraZeneca vaccine has been paused in Norway,” Health Minister Bent Høie said in a statement.

The 216,000 doses, which are currently stored in Norwegian fridges, have to be used before their expiry dates in June and July.

Sweden will receive 200,000 shots and Iceland 16,000 under the expectation they will return the favour at some point. 

“If we do resume the use of the AstraZeneca vaccine, we will get the doses back as soon as we ask,” Høie said.

Like neighbouring Denmark, Norway suspended the use of the AstraZeneca jab on March 11 in order to examine rare but potentially severe side effects, including blood clots.

Among the 134,000 AstraZeneca shots administered in Norway before the suspension, five cases of severe thrombosis, including three fatal ones, had been registered among relatively young people in otherwise good health. One other person died of a brain haemorrhage.

On April 15, Norway’s government ignored a recommendation from the Institute of Public Health to drop the AstraZeneca jab for good, saying it wanted more time to decide.

READ MORE: Norway delays final decision on withdrawal of AstraZeneca vaccine 

The government has therefore set up a committee of Norwegian and international experts tasked with studying all of the risks linked to the AstraZeneca and Johnson & Johnson vaccines, which is also suspected of causing blood clots.

Both are both based on adenovirus vector technology. Denmark is the only European country to have dropped the AstraZeneca
vaccine from its vaccination campaign, and said on Tuesday it would “lend” 55,000 doses to the neighbouring German state of Schleswig-Holstein.